Login / Signup

An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy.

Yun WangYan-Yu CaiTobias HeroldRun-Cong NieYu ZhangRobert Peter GaleKlaus H MetzelerYun ZengShun-Qing WangXue-Yi PanTong-Hua YangYuan-Bin WuQing ZhangZhi-Jun WuxiaoXin DuZhi-Wei LiangYong-Zhong SuJing-Bo XuYong-Qing WangZe-Lin LiuJian-Wei WuXiong ZhangBing-Yi WuRuo-Zhi XiaoSan-Bin WangJin-Yuan LiPei-Dong ChiQian-Yi ZhangSi-Liang ChenZhe-Yuan QinXin-Mei ZhangNa ZhongWolfgang HiddemannQi-Fa LiuBei Zhang
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Our immune risk score complements current AML prediction models.
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • locally advanced
  • squamous cell carcinoma
  • free survival
  • acute lymphoblastic leukemia
  • rectal cancer